O. Hilberg (Aarhus, Denmark), B. Kalsdorf (Borstel, Germany)
Hyponatraemia in tuberculosis
S. Blankley, C. Rollason, B. Graham (London, United Kingdom)
|  |
The evaluation of tuberculosis risk in diabetes mellitus patients in a high incidence of tuberculosis region
M. Olteanu, M. Nitu, A. Golli, M. Olteanu, D. Medregoniu, A. Voicu-Maceseanu, V. Grecu, C. Didilescu (Craiova, Romania)
| |
The impact of glycemic control on the treatment outcomes of the patients with pulmonary tuberculosis and DM
J. W. Moon, J. H. Bae, Y. W. Moon, E. Y. Kim, J. E. Lim, J. Y. Jung, J. Y. Son, Y. A. Kang, M. S. Park, Y. S. Kim, S. K. Kim, J. Chang, S. Y. Kim, S. K. Lee, B. H. Park, S. H. Lee, K. J. Lee (Seoul, Republic Of Korea)
| |
Does diabetes mellitus affect T-cell interferon-gamma responses in TB patients?
S. H. Gan, K. W. KhinMar, T. Barkham, C. K. Koh, Y. T. Wang, C. B. E. Chee (Singapore, Singapore)
|  |
The prevalence of hypovitaminosis D among newly diagnosed TB patients in Mumbai, India
A. Mahashur, L. Pinto (Mumbai, India)
| |
Vitamin C levels in Indian patients with active pulmonary tuberculosis
G. D'Souza, S. Rangarajan, D. Viradia (Brooklyn, United States Of America; Bangalore, India)
| |
The level of serum vitamin D is a good predictor of prolonged hospitalization in patients with tuberculosis
S. Sato, T. Nikaido, A. Fukuhara, K. Saito, N. Nakagawa, Y. Inokoshi, T. Ishii, X. Wang, J. Saito, Y. Tanino, T. Ishida, M. Munakata (Fukushima, Japan)
| |
Vitamin D deficiency and outcome of tuberculosis therapy – A retrospective cohort study
D. Roberts, H. Kunst, A. Wood (Birmingham, United Kingdom)
| |
Impact of diabetes in the expression of tuberculosis
S. Carreira, J. Costeira, C. Gomes, J. André, N. Diogo (Lisbon, Portugal)
| |
The epidemiology of diabetes mellitus – Tuberculosis association in a Romanian region
M. Nitu, A. Golli, M. Olteanu, D. Medregoniu, M. Olteanu, A. Voicu-Maceseanu, V. Grecu, I. Bazavan (Craiova, Romania)
| |
Serum Cu, Fe and Zn concentrations and their relation to the inflammation associated with active pulmonary tuberculosis
R. I. Cernat, T. Mihaescu, R. D. Mocanu, R. I. Olariu, C. Arsene (Iasi, Romania)
| |
Latent TB screening before anti-TNFα treatment
R. Lungu, A. Croitoru, D. Bumbacea (Bucharest, Romania)
| |
Effectiveness of official recommendations on tuberculosis screening in patients on TNF antagonists
R. Monteiro, I. Gonçalves, F. Calvário, A. Carvalho, R. Duarte (Vng, Porto, Portugal)
| |
Should tobacco discontinuation be part of tuberculosis control program?
C. S. Pinto, F. Soares Pires, A. Carvalho, R. Duarte (Vila Nova de Gaia, Vila Real, Porto, Portugal)
| |
Is it smoking a risk factor in tuberculosis?
M. Stoleru (Piatra Neamt, Romania)
| |
Influence of smoking in pulmonary tuberculosis
W. El Khattabi, A. Aichane, H. Afif, A. Hebbazi, N. Belakhal, Z. Bouayad (Casablanca, Morocco)
| |
The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis
R. Abdullayev, O. Komissarova, G. Kaminskaya (Moscow, Russian Federation)
| |
Tuberculin hypersensitivity and its relation to nutritional status in patients with active pulmonary tuberculosis
S. Michaelides, V. Chandrinos, I. Hatzimanolis, G. Bablekos, I. Nikolakopoulos, A. Lekakou, P. Mania (Athens, Greece)
| |
Diagnosis post-vaccination BCG-lymphadenitis
L. Kasenova (Allschwill, Kazakhstan)
| |
Effects of shaking methods of blood collection tubes on QuantiFERON®-TB Gold In-Tube assays
K. Higuchi, N. Harada, Y. Sekiya (Kiyose, Japan)
| |